Advertisement

Prediction of major adverse cardiovascular events by age-normalized carotid intimal medial thickness

      Abstract

      Background

      Increases in carotid intimal medial thickness (IMT), as measured by noninvasive ultrasonography, have been associated with increased risk of myocardial infarction and stroke, particularly in adults 65 years of age or older. We investigated the value of age-normalized carotid IMT measurements in predicting major adverse cardiovascular events in a population of patients referred for carotid IMT measurement.

      Methods

      Since 1995, 727 patients had carotid IMT measured at the University of Virginia's Preventive Cardiology practice. We successfully contacted 706 of these patients to determine clinical outcomes; 21 patients were lost to follow-up. The 706 patients were entered into a database, age-specific quartiles of carotid thickness developed, and odds ratios were calculated with logistic regression.

      Results

      Over a mean follow-up period of 4.78 years (range, 2.0–9.3 years), 20 patients had major adverse cardiovascular events: seven patients had myocardial infarctions; seven required revascularization; and six had a stroke or transient ischemic attack. The incidence of events directly correlated with age-normalized measurements of carotid bulb and internal carotid IMT. The highest quartile of carotid bulb IMT demonstrated an odds ratio for all events of 5.8 (95% confidence interval, 1.3–26.6; P = 0.023) when compared to the quartile with the lowest thickness (P = 0.007 for trend). A similar trend for quartiles of internal carotid IMT was also observed (P = 0.03). Common carotid IMT did not significantly predict events.

      Conclusions

      Age-normalized measurement of carotid bulb and internal carotid IMT may be helpful in determining which individuals would most benefit from aggressive risk-factor modification.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • O’Leary D.H.
        • Polak J.F.
        Intima-media thickness: a tool for atherosclerosis imaging and event prediction.
        Am J Cardiol. 2002; 90: 18L-21L
        • Fathi R.
        • Marwick T.H.
        Noninvasive tests of vascular function and structure: why and how to perform them.
        Am Heart J. 2001; 141: 694-703
        • Smith Jr., S.C.
        • Greenland P.
        • Grundy S.M.
        Circulation. 2000; 101: 111-116
        • Taylor A.J.
        • Sullenberger L.E.
        • Lee H.J.
        • Lee J.K.
        • Grace K.A.
        Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER). 2. A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.
        Circulation. 2004; 110: 3512-3517
        • Burke G.L.
        • Evans G.W.
        • Riley W.A.
        • et al.
        Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The atherosclerosis risk in communities (ARIC) study.
        Stroke. 1995; 26: 386-391
        • Chambless L.E.
        • Heiss G.
        • Folsom A.R.
        • et al.
        Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors the atherosclerosis risk in communities (ARIC) study 1987–1993.
        Am J Epidemiol. 1997; 146: 483-494
        • Bots M.L.
        • Hoes A.W.
        • Koudstaal P.J.
        • Hofman A.
        • Grobbee D.E.
        Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study.
        Circulation. 1997; 96: 1432-1437
        • Bots M.L.
        • Hofman A.
        • Grobbee D.E.
        Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam study.
        Stroke. 1997; 28: 2442-2447
        • Ebrahim S.
        • Papacosta O.
        • Whincup P.
        • et al.
        Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British regional heart study.
        Stroke. 1999; 30: 841-850
        • O’Leary D.H.
        • Polak J.F.
        • Kronmal R.A.
        • et al.
        Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults.
        N Engl J Med. 1999; 340: 14-22
        • Belcaro G.
        • Nicolaides A.N.
        • Ramaswami G.
        • et al.
        Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study).
        Atherosclerosis. 2001; 156: 379-387
        • Rembold K.E.
        • Ayers C.R.
        • Wills M.B.
        • Rembold C.M.
        Usefulness of carotid initmal medial thickness and flow mediated dilation in a preventive cardiology practice.
        Am J Cardiol. 2003; 91: 1475-1477
        • Ryan T.J.
        • Antman E.M.
        • Brooks N.H.
        • et al.
        1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
        J Am Coll Cardiol. 1999; 34: 890-909
        • Ryan T.J.
        • Antman E.M.
        • Brooks N.P.
        • et al.
        Update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
        Circulation. 1999; 100: 1016-1030
        • Grundy S.M.
        • Cleeman J.I.
        • Merz CNB
        • et al.
        Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines.
        Circulation. 2004; 110: 227-239